Maravai Lifesciences Holdings Stock Analysis

Maravai Stock Analysis Notes

About 99.0% of the company shares are owned by institutional investors. The book value of Maravai Lifesciences was now reported as 2.44. The company recorded a loss per share of 1.67. Maravai Lifesciences had not issued any dividends in recent years. Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. Maravai LifeSciences Holdings, Inc. was incorporated in 2020 and is headquartered in San Diego, California. Maravai LifeSciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 470 people. To find out more about Maravai Lifesciences Holdings contact the company at 858 546 0004 or learn more at https://www.maravai.com.

Maravai Lifesciences Investment Alerts

Maravai Lifesciences Upcoming and Recent Events

Maravai Largest EPS Surprises

View All Earnings Estimates

Maravai Lifesciences Environmental, Social, and Governance (ESG) Scores

Maravai Lifesciences Thematic Classifications

Maravai Stock Institutional Investors

Note, although Maravai Lifesciences' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Maravai Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.37 B.

Maravai Profitablity

The company has Profit Margin (PM) of (0.81) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.23) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.23.

Management Efficiency

Maravai Lifesciences has return on total asset (ROA) of (0.0161) % which means that it has lost $0.0161 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4293) %, meaning that it created substantial loss on money invested by shareholders. Maravai Lifesciences' management efficiency ratios could be used to measure how well Maravai Lifesciences manages its routine affairs as well as how well it operates its assets and liabilities. The Maravai Lifesciences' current Return On Tangible Assets is estimated to increase to -0.12. The Maravai Lifesciences' current Return On Capital Employed is estimated to increase to -0.02. As of now, Maravai Lifesciences' Intangibles To Total Assets are decreasing as compared to previous years. The Maravai Lifesciences' current Debt To Assets is estimated to increase to 0.46, while Total Assets are projected to decrease to under 1.5 B.

Technical Drivers

As of the 12th of December 2024, Maravai Lifesciences secures the Risk Adjusted Performance of (0.04), standard deviation of 6.25, and Mean Deviation of 3.84. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Maravai Lifesciences, as well as the relationship between them.

Maravai Lifesciences Price Movement Analysis

Maravai Lifesciences Insider Trading Activities

Maravai Lifesciences Outstanding Bonds

Maravai Lifesciences Predictive Daily Indicators

Maravai Lifesciences Corporate Filings

Maravai Lifesciences Forecast Models

Maravai Lifesciences' time-series forecasting models are one of many Maravai Lifesciences' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Maravai Lifesciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Maravai Lifesciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Maravai shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Maravai Lifesciences. By using and applying Maravai Stock analysis, traders can create a robust methodology for identifying Maravai entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Maravai analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Maravai analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Maravai Lifesciences Holdings stock analysis indicators help investors evaluate how Maravai Lifesciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Maravai Lifesciences shares will generate the highest return on investment. By understating and applying Maravai Lifesciences stock analysis, traders can identify Maravai Lifesciences position entry and exit signals to maximize returns.

When running Maravai Lifesciences' price analysis, check to measure Maravai Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Maravai Lifesciences is operating at the current time. Most of Maravai Lifesciences' value examination focuses on studying past and present price action to predict the probability of Maravai Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Maravai Lifesciences' price. Additionally, you may evaluate how the addition of Maravai Lifesciences to your portfolios can decrease your overall portfolio volatility.